ArticleInflammatory bowel diseases2019

Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort.

Martin Gregory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.